SCHEMBL9752038

SCHEMBL9752038

O=C(O)C1(Cl)C=c2ccccc2=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6688749 0.77 THRB (0.31)
SCHEMBL27898695 0.75 NPC1 (0.31)
SCHEMBL31567994 0.74
SCHEMBL10783455 0.74 L3MBTL1 (0.32)
SCHEMBL27768567 0.71 TSHR (0.34)
SCHEMBL28064401 0.68
SCHEMBL8074486 0.67 PKM (0.37)
SCHEMBL7270073 0.67 PKM (0.37)
SCHEMBL1847048 0.67 PKM (0.37)
SCHEMBL31202874 0.66 PKM (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013190212-A1 METHOD FOR PRODUCING CHIRAL PEPTIDES DIVERCHIM (FR) 2013-12-27 WO disclosed
EP-0449884-A4 DERIVATIVES OF TETRAPEPTIDES AS CCK AGONISTS 1991-10-30 EP disclosed
EP-0449884-A1 DERIVATIVES OF TETRAPEPTIDES AS CCK AGONISTS ABBOTT LABORATORIES (US) 1991-10-09 EP disclosed
WO-1990006937-A1 DERIVATIVES OF TETRAPEPTIDES AS CCK AGONISTS ABBOTT LABORATORIES (US) 1990-06-28 WO disclosed